Nitrate tolerance

Nitrates are widely used in anginal prophylaxis. In spite of the fact that the concept of nitrate tolerance was first put forward many years ago, the question of tolerance has remained controversial. There is widespread agreement that tolerance does occur to the effects of nitrates on arterial press...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Cardiology 1986-07, Vol.12 (1), p.1-19
1. Verfasser: Cowan, J.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19
container_issue 1
container_start_page 1
container_title International Journal of Cardiology
container_volume 12
creator Cowan, J.C.
description Nitrates are widely used in anginal prophylaxis. In spite of the fact that the concept of nitrate tolerance was first put forward many years ago, the question of tolerance has remained controversial. There is widespread agreement that tolerance does occur to the effects of nitrates on arterial pressure. In contrast, tolerance to the venous and pulmonary effects is disputed. Similarly, the possibility of tolerance to the antianginal effects remains at issue. In this review, I discuss the factors which may have contributed to conflicting results in different studies, in particular recent findings on the rapidity of onset and reversal of tolerance. Tolerance develops rapidly on initiation of treatment and disappears equally rapidly on its discontinuation. In addition, tolerance appears to be a function of plasma nitrate profile. It is most likely to occur when plasma nitrate levels are constant and least likely when nitrate levels fluctuate. Furthermore, the provision of a daily nitrate free interval may protect against the development of tolerance. I then discuss the implications of these findings for patient management. They suggest that nitrate prophylaxis should not be used continuously, if this can be avoided. Rather, prophylaxis should be tailored to the individual to provide protection at times of maximum susceptibility, while allowing nitrate levels to fall at other times. The adequacy of antianginal protection with drug regimens incorporating a nitrate free interval requires further assessment. Similarly, the possibility that a nitrate free interval might lead to withdrawal effects and exacerbation of angina needs to be excluded.
doi_str_mv 10.1016/0167-5273(86)90094-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76957797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>016752738690094X</els_id><sourcerecordid>76957797</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-d2a408de1f16fcc4ce265391255ee8689f41545cfb3a0b0857fde02f2b513f753</originalsourceid><addsrcrecordid>eNp9kM1Lw0AQxRdRaq0evCt4ENFDdDbZz0tBil9Q9KLQ27LZzMJK2tTdVPC_N7GhRw_DHOb3HvMeIWcUbilQcdeNzHgui2slbjSAZtlij4ypkiyjkrN9Mt4hh-QopU8AYFqrERkVoLRmckxOX0MbbYsXbVNjtCuHx-TA2zrhybAn5OPx4X32nM3fnl5m9_PMFUq0WZVbBqpC6qnwzjGHueCFpjnniEoo7RnljDtfFhZKUFz6CiH3eclp4SUvJuRq67uOzdcGU2uWITmsa7vCZpOMFJpLqWUHsi3oYpNSRG_WMSxt_DEUTN-E6WOaPqZRwvw1YRad7Hzw35RLrHaiIXp3vxzuNjlb-z58SDtMAQPIocOmWwy7Lr4DRpNcwK6nKkR0rama8P8fv-VCd7s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76957797</pqid></control><display><type>article</type><title>Nitrate tolerance</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Cowan, J.C.</creator><creatorcontrib>Cowan, J.C.</creatorcontrib><description>Nitrates are widely used in anginal prophylaxis. In spite of the fact that the concept of nitrate tolerance was first put forward many years ago, the question of tolerance has remained controversial. There is widespread agreement that tolerance does occur to the effects of nitrates on arterial pressure. In contrast, tolerance to the venous and pulmonary effects is disputed. Similarly, the possibility of tolerance to the antianginal effects remains at issue. In this review, I discuss the factors which may have contributed to conflicting results in different studies, in particular recent findings on the rapidity of onset and reversal of tolerance. Tolerance develops rapidly on initiation of treatment and disappears equally rapidly on its discontinuation. In addition, tolerance appears to be a function of plasma nitrate profile. It is most likely to occur when plasma nitrate levels are constant and least likely when nitrate levels fluctuate. Furthermore, the provision of a daily nitrate free interval may protect against the development of tolerance. I then discuss the implications of these findings for patient management. They suggest that nitrate prophylaxis should not be used continuously, if this can be avoided. Rather, prophylaxis should be tailored to the individual to provide protection at times of maximum susceptibility, while allowing nitrate levels to fall at other times. The adequacy of antianginal protection with drug regimens incorporating a nitrate free interval requires further assessment. Similarly, the possibility that a nitrate free interval might lead to withdrawal effects and exacerbation of angina needs to be excluded.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/0167-5273(86)90094-X</identifier><identifier>PMID: 3089947</identifier><identifier>CODEN: IJCDD5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>angina pectoris ; Angina Pectoris - drug therapy ; Antianginal agents. Coronary vasodilator agents ; Biological and medical sciences ; Cardiovascular system ; Drug Tolerance ; heart failure ; Hemodynamics - drug effects ; Humans ; Male ; Medical sciences ; nitrates ; Nitrates - administration &amp; dosage ; Nitrates - blood ; Nitrates - metabolism ; Nitrates - pharmacology ; Nitrates - therapeutic use ; Nitroglycerin - administration &amp; dosage ; nitroglycerin patches ; Pharmacology. Drug treatments ; Time Factors</subject><ispartof>International Journal of Cardiology, 1986-07, Vol.12 (1), p.1-19</ispartof><rights>1986</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-d2a408de1f16fcc4ce265391255ee8689f41545cfb3a0b0857fde02f2b513f753</citedby><cites>FETCH-LOGICAL-c386t-d2a408de1f16fcc4ce265391255ee8689f41545cfb3a0b0857fde02f2b513f753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0167-5273(86)90094-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,315,781,785,793,3551,27924,27926,27927,45997</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8040020$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3089947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cowan, J.C.</creatorcontrib><title>Nitrate tolerance</title><title>International Journal of Cardiology</title><addtitle>Int J Cardiol</addtitle><description>Nitrates are widely used in anginal prophylaxis. In spite of the fact that the concept of nitrate tolerance was first put forward many years ago, the question of tolerance has remained controversial. There is widespread agreement that tolerance does occur to the effects of nitrates on arterial pressure. In contrast, tolerance to the venous and pulmonary effects is disputed. Similarly, the possibility of tolerance to the antianginal effects remains at issue. In this review, I discuss the factors which may have contributed to conflicting results in different studies, in particular recent findings on the rapidity of onset and reversal of tolerance. Tolerance develops rapidly on initiation of treatment and disappears equally rapidly on its discontinuation. In addition, tolerance appears to be a function of plasma nitrate profile. It is most likely to occur when plasma nitrate levels are constant and least likely when nitrate levels fluctuate. Furthermore, the provision of a daily nitrate free interval may protect against the development of tolerance. I then discuss the implications of these findings for patient management. They suggest that nitrate prophylaxis should not be used continuously, if this can be avoided. Rather, prophylaxis should be tailored to the individual to provide protection at times of maximum susceptibility, while allowing nitrate levels to fall at other times. The adequacy of antianginal protection with drug regimens incorporating a nitrate free interval requires further assessment. Similarly, the possibility that a nitrate free interval might lead to withdrawal effects and exacerbation of angina needs to be excluded.</description><subject>angina pectoris</subject><subject>Angina Pectoris - drug therapy</subject><subject>Antianginal agents. Coronary vasodilator agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Drug Tolerance</subject><subject>heart failure</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>nitrates</subject><subject>Nitrates - administration &amp; dosage</subject><subject>Nitrates - blood</subject><subject>Nitrates - metabolism</subject><subject>Nitrates - pharmacology</subject><subject>Nitrates - therapeutic use</subject><subject>Nitroglycerin - administration &amp; dosage</subject><subject>nitroglycerin patches</subject><subject>Pharmacology. Drug treatments</subject><subject>Time Factors</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1Lw0AQxRdRaq0evCt4ENFDdDbZz0tBil9Q9KLQ27LZzMJK2tTdVPC_N7GhRw_DHOb3HvMeIWcUbilQcdeNzHgui2slbjSAZtlij4ypkiyjkrN9Mt4hh-QopU8AYFqrERkVoLRmckxOX0MbbYsXbVNjtCuHx-TA2zrhybAn5OPx4X32nM3fnl5m9_PMFUq0WZVbBqpC6qnwzjGHueCFpjnniEoo7RnljDtfFhZKUFz6CiH3eclp4SUvJuRq67uOzdcGU2uWITmsa7vCZpOMFJpLqWUHsi3oYpNSRG_WMSxt_DEUTN-E6WOaPqZRwvw1YRad7Hzw35RLrHaiIXp3vxzuNjlb-z58SDtMAQPIocOmWwy7Lr4DRpNcwK6nKkR0rama8P8fv-VCd7s</recordid><startdate>19860701</startdate><enddate>19860701</enddate><creator>Cowan, J.C.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19860701</creationdate><title>Nitrate tolerance</title><author>Cowan, J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-d2a408de1f16fcc4ce265391255ee8689f41545cfb3a0b0857fde02f2b513f753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>angina pectoris</topic><topic>Angina Pectoris - drug therapy</topic><topic>Antianginal agents. Coronary vasodilator agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Drug Tolerance</topic><topic>heart failure</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>nitrates</topic><topic>Nitrates - administration &amp; dosage</topic><topic>Nitrates - blood</topic><topic>Nitrates - metabolism</topic><topic>Nitrates - pharmacology</topic><topic>Nitrates - therapeutic use</topic><topic>Nitroglycerin - administration &amp; dosage</topic><topic>nitroglycerin patches</topic><topic>Pharmacology. Drug treatments</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cowan, J.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International Journal of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cowan, J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitrate tolerance</atitle><jtitle>International Journal of Cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>1986-07-01</date><risdate>1986</risdate><volume>12</volume><issue>1</issue><spage>1</spage><epage>19</epage><pages>1-19</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><coden>IJCDD5</coden><abstract>Nitrates are widely used in anginal prophylaxis. In spite of the fact that the concept of nitrate tolerance was first put forward many years ago, the question of tolerance has remained controversial. There is widespread agreement that tolerance does occur to the effects of nitrates on arterial pressure. In contrast, tolerance to the venous and pulmonary effects is disputed. Similarly, the possibility of tolerance to the antianginal effects remains at issue. In this review, I discuss the factors which may have contributed to conflicting results in different studies, in particular recent findings on the rapidity of onset and reversal of tolerance. Tolerance develops rapidly on initiation of treatment and disappears equally rapidly on its discontinuation. In addition, tolerance appears to be a function of plasma nitrate profile. It is most likely to occur when plasma nitrate levels are constant and least likely when nitrate levels fluctuate. Furthermore, the provision of a daily nitrate free interval may protect against the development of tolerance. I then discuss the implications of these findings for patient management. They suggest that nitrate prophylaxis should not be used continuously, if this can be avoided. Rather, prophylaxis should be tailored to the individual to provide protection at times of maximum susceptibility, while allowing nitrate levels to fall at other times. The adequacy of antianginal protection with drug regimens incorporating a nitrate free interval requires further assessment. Similarly, the possibility that a nitrate free interval might lead to withdrawal effects and exacerbation of angina needs to be excluded.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>3089947</pmid><doi>10.1016/0167-5273(86)90094-X</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-5273
ispartof International Journal of Cardiology, 1986-07, Vol.12 (1), p.1-19
issn 0167-5273
1874-1754
language eng
recordid cdi_proquest_miscellaneous_76957797
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects angina pectoris
Angina Pectoris - drug therapy
Antianginal agents. Coronary vasodilator agents
Biological and medical sciences
Cardiovascular system
Drug Tolerance
heart failure
Hemodynamics - drug effects
Humans
Male
Medical sciences
nitrates
Nitrates - administration & dosage
Nitrates - blood
Nitrates - metabolism
Nitrates - pharmacology
Nitrates - therapeutic use
Nitroglycerin - administration & dosage
nitroglycerin patches
Pharmacology. Drug treatments
Time Factors
title Nitrate tolerance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T17%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitrate%20tolerance&rft.jtitle=International%20Journal%20of%20Cardiology&rft.au=Cowan,%20J.C.&rft.date=1986-07-01&rft.volume=12&rft.issue=1&rft.spage=1&rft.epage=19&rft.pages=1-19&rft.issn=0167-5273&rft.eissn=1874-1754&rft.coden=IJCDD5&rft_id=info:doi/10.1016/0167-5273(86)90094-X&rft_dat=%3Cproquest_cross%3E76957797%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76957797&rft_id=info:pmid/3089947&rft_els_id=016752738690094X&rfr_iscdi=true